All Stories

  1. GSK3 Inhibitors in the Therapeutic Development of Diabetes, Cancer and Neurodegeneration: Past, Present and Future

    Article • Current Pharmaceutical Design, November 2017, Bentham Science Publishers

    Dr Nasimul Hoda, Mudasir Maqbool